Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaccinex Inc (NQ: VCNX )

0.4022 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.4022
Bid (Size) 0.4000 (1)
Ask (Size) 0.4399 (4)
Prev. Close 0.4022
Today's Range 0.4022 - 0.4022
52wk Range 0.3899 - 1.500
Shares Outstanding 42,718,957
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 74 companies achieved new lows for the year. 
Via Benzinga
Vaccinex Announces Initiation of Single-Arm Open Label, Phase Ib/2 Study to Evaluate Pepinemab in Combination with Avelumab as Second Line Combination Immunotherapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
From Vaccinex, Inc.
Via Globe NewsWire

Performance

YTD
-36.37%
-36.37%
1 Month
-16.21%
-16.21%
3 Month
-39.97%
-39.97%
6 Month
-38.60%
-38.60%
1 Year
-71.87%
-71.87%

More News

Read More
Why Is Vaccinex (VCNX) Stock Up 67% Today?
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Vaccinex Reports that KEYNOTE B-84 has Reached Targeted Enrollment for Pre-planned Interim Analysis
From Vaccinex, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
MarketBeat Week in Review – 2/6 - 2/10
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy Interest Rates
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Should Investors Buy or Sell the Vaccinex Patent News?
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Why Is Rubius Therapeutics (RUBY) Stock Down 16% Today?
Via InvestorPlace
Why Is Bed Bath & Beyond (BBBY) Stock Down 32% Today?
Via InvestorPlace
Why Is Oak Street Health (OSH) Stock Up 36% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
The 3 Best Biotech Stocks Under $1 to Buy for January
Via InvestorPlace
Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology
From Vaccinex, Inc.
Via Globe NewsWire
Vaccinex Announces $3.8 Million Private Placement
From Vaccinex, Inc.
Via Globe NewsWire
Vaccinex Reports Third Quarter 2022 Results and Provides Corporate Update
From Vaccinex, Inc.
Via Globe NewsWire
Vaccinex and its Collaborators Present Two Abstracts Related to Pepinemab Combination Immunotherapy Trials at 37th Annual Meeting of Society for Immunotherapy of Cancer
From Vaccinex, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.